Calici’s research team is proud to announce the publication of our second co-authored paper.
This study centers on blood glucose regulation through activation of the insulin signaling pathway, presenting significant findings with potential clinical implications.
Co-authored by Dr. Young Bin Park and Dr. Jae-Mun Choi, the research demonstrates that the natural compound Chiisanogenin promotes glucose uptake and effectively lowers blood glucose levels by activating insulin signaling.
Published in the international journal Biomedicine & Pharmacotherapy, this work opens new avenues for therapeutic development targeting metabolic diseases.
Calici remains committed to advancing AI-driven drug discovery toward practical treatments !